Serum β2-Microglobulin is Associated with Mortality in Hospitalized Patients with Exacerbated Chronic Obstructive Pulmonary Disease
Serum β2-Microglobulin is Associated with Mortality in Hospitalized Patients with Exacerbated Chronic Obstructive Pulmonary Disease
复制标题
血清 β2-微球蛋白与慢性阻塞性肺疾病加重住院患者的死亡率相关
DOI:
10.2147/copd.s243905
复制
发表时间:
2020-01-01
影响因子:
2.8
通讯作者:
Huang, Kewu
中科院分区:
文献类型:
--
作者:
Mao, Wenping;Wang, Jing;Huang, Kewu
Purpose: We hypothesized that increased level of serum beta 2-microglobulin (beta 2M) is an independent factor associated with higher mortality in hospitalized patients with exacerbated chronic obstructive pulmonary disease (COPD).Patients and Methods: We retrospectively analyzed 488 hospitalized patients with exacerbated COPD as the first diagnosis at Beijing Chao-Yang hospital, P. R. China between December 31st, 2012 and December 28th, 2017. Concentrations of serum beta 2M and other clinical indexes were measured or collected on admission, and all patients were followed up to 90 days. The relationship between beta 2M and 30- and 90-day all-cause mortality was explored by Cox regression analysis adjusted for age, C-reactive protein values, N-terminal pro-brain natriuretic peptide/100, respiratory failure [RF, defined as partial arterial oxygen pressure (PaO2)